Skip to content

Public FDA record

Z-0983-05: TaqMan HBV Analyte Specific Reagent, Material Number 3322092018, containing HBV Quantitation Standard (HB

Recall record Z-0983-05 for Roche Molecular Systems Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0983-05
Company in FDA record
Roche Molecular Systems Inc
FDA classification date
Jul 13, 2005
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Low level of recombinant HIV DNA found in one lot of HBV QS which is a component of one lot of the TaqMan HBV ASR.

Source facts

Action
Notification letter to LabCorp wa sent on 2/14/2005 via FedEx.
Initiated
2005-02-14
Root cause
Other
Terminated
2006-10-03
Distribution
One customers received 14 kits on 1/3/2005. This one customer was LabCorp, 1912 Alexander Drive, Research Triangle Park, NC 27709.
Recall number
Z-0983-05
Recall status
Terminated
CDRH record ID
37275
FDA classified
2005-07-13
Recall event number
31161

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗